Olbjørn Klepp

8.1k total citations · 1 hit paper
106 papers, 4.8k citations indexed

About

Olbjørn Klepp is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Olbjørn Klepp has authored 106 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Surgery, 29 papers in Pulmonary and Respiratory Medicine and 27 papers in Oncology. Recurrent topics in Olbjørn Klepp's work include Testicular diseases and treatments (52 papers), Sexual Differentiation and Disorders (15 papers) and Childhood Cancer Survivors' Quality of Life (12 papers). Olbjørn Klepp is often cited by papers focused on Testicular diseases and treatments (52 papers), Sexual Differentiation and Disorders (15 papers) and Childhood Cancer Survivors' Quality of Life (12 papers). Olbjørn Klepp collaborates with scholars based in Norway, Sweden and United States. Olbjørn Klepp's co-authors include Sophie D. Fosså, Roy M. Bremnes, Olav Dahl, Arne Solberg, Erik Wist, Fredrik Wiklund, Nina Aass, Anders Widmark, J.‐E. Damber and Olav Dahl and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Olbjørn Klepp

104 papers receiving 4.6k citations

Hit Papers

Endocrine treatment, with or without radiotherapy, in loc... 2008 2026 2014 2020 2008 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
    2008 594 citations Anders Widmark, Olbjørn Klepp et al. profile →

Peers

Olbjørn Klepp
Marc B. Garnick United States
Robert Birch United States
Kevin R. Loughlin United States
J.T. Roberts United Kingdom
Benjamin W. Corn United States
Robert J. Hamilton Canada
James Paul United Kingdom
Clair J. Beard United States
Florence Joly France
William M. Burke United States
Marc B. Garnick United States
Olbjørn Klepp
Citations per year, relative to Olbjørn Klepp Olbjørn Klepp (= 1×) peers Marc B. Garnick

Countries citing papers authored by Olbjørn Klepp

Since Specialization
Citations

This map shows the geographic impact of Olbjørn Klepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olbjørn Klepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olbjørn Klepp more than expected).

Fields of papers citing papers by Olbjørn Klepp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olbjørn Klepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olbjørn Klepp. The network helps show where Olbjørn Klepp may publish in the future.

Co-authorship network of co-authors of Olbjørn Klepp

This figure shows the co-authorship network connecting the top 25 collaborators of Olbjørn Klepp. A scholar is included among the top collaborators of Olbjørn Klepp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olbjørn Klepp. Olbjørn Klepp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beisland, Christian, T.B. Johannesen, Olbjørn Klepp, et al.. (2017). Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study. OncoTargets and Therapy. Volume 10. 371–385. 27 indexed citations
2.
Karlsson, Robert, Wenche Kristiansen, Elin L. Aschim, et al.. (2013). Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4. Human Molecular Genetics. 22(16). 3373–3380. 23 indexed citations
3.
Hoff, Solveig Roth, Olbjørn Klepp, & Solveig Hofvind. (2012). Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?. Journal of Medical Screening. 19(4). 177–183. 6 indexed citations
4.
5.
Kristiansen, Wenche, Robert Karlsson, Elin L. Aschim, et al.. (2012). Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case–parent triad study in a Norwegian–Swedish population. Human Reproduction. 27(5). 1525–1535. 14 indexed citations
6.
Tandstad, Torgrim, Rune Smaaland, Arne Solberg, et al.. (2011). Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group. Journal of Clinical Oncology. 29(6). 719–725. 141 indexed citations
7.
Tandstad, Torgrim, Gabriella Cohn‐Cedermark, O. Dahl, et al.. (2010). Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. Annals of Oncology. 21(9). 1858–1863. 34 indexed citations
8.
Fransson, Per-Anders, Jo-Åsmund Lund, J.‐E. Damber, et al.. (2009). Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial. The Lancet Oncology. 10(4). 370–380. 65 indexed citations
9.
Steinsbekk, Aslak, et al.. (2008). Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Supportive Care in Cancer. 16(7). 763–769. 47 indexed citations
10.
Dahl, Alv A., Roy M. Bremnes, Olav Dahl, et al.. (2007). Is the Sexual Function Compromised in Long-Term Testicular Cancer Survivors?. European Urology. 52(5). 1438–1447. 88 indexed citations
11.
Sundstrøm, Stein, Roy M. Bremnes, Paal Brunsvig, et al.. (2005). Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study. Radiotherapy and Oncology. 75(2). 141–148. 23 indexed citations
12.
Risberg, Terje, Arne Kolstad, Erik A. Wist, et al.. (2003). [Should alternative therapists treat cancer--what is the opinion of oncology health personnel?].. PubMed. 123(21). 3059–61.
13.
Widmark, Anders, Sophie D. Fosså, P.I. Lundmo, et al.. (2003). Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology. 61(1). 145–151. 68 indexed citations
14.
Tandstad, Torgrim & Olbjørn Klepp. (2003). Neuron-specific Enolase in Testicular Cancer. Acta Oncologica. 42(3). 202–206. 8 indexed citations
15.
Norderhaug, Inger Natvig, Truls E. Bjerklund Johansen, Per Å. Høisæter, et al.. (2002). Brakyterapi ved prostatakreft. University of Southern Denmark Research Portal (University of Southern Denmark). 122. 1 indexed citations
16.
Haux, Johan, Olbjørn Klepp, Olav Spigset, & Steinar Tretli. (2001). Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer. 1(1). 11–11. 124 indexed citations
17.
Klepp, Olbjørn, O. Dahl, Per Flodgren, et al.. (1997). Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer. European Journal of Cancer. 33(7). 1038–1044. 60 indexed citations
18.
Aass, Nina, Olbjørn Klepp, Eva Cavallin‐Ståhl, et al.. (1991). Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.. Journal of Clinical Oncology. 9(5). 818–826. 121 indexed citations
19.
Klepp, Olbjørn, et al.. (1990). Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Annals of Oncology. 1(4). 281–288. 41 indexed citations
20.
BERGHOLTZ, B. O., et al.. (1977). HLA antigens in malignant melanoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16. 175–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc B. Garnick Breakdown of academic impact, for papers by Robert Birch Breakdown of academic impact, for papers by Kevin R. Loughlin Breakdown of academic impact, for papers by J.T. Roberts Breakdown of academic impact, for papers by Benjamin W. Corn Breakdown of academic impact, for papers by Robert J. Hamilton Breakdown of academic impact, for papers by James Paul Breakdown of academic impact, for papers by Clair J. Beard Breakdown of academic impact, for papers by Florence Joly Breakdown of academic impact, for papers by William M. Burke
Rankless by CCL
2026